152 related articles for article (PubMed ID: 32382514)
41. Selenium-binding protein 1: a sensitive urinary biomarker to detect heavy metal-induced nephrotoxicity.
Lee EK; Shin YJ; Park EY; Kim ND; Moon A; Kwack SJ; Son JY; Kacew S; Lee BM; Bae ON; Kim HS
Arch Toxicol; 2017 Apr; 91(4):1635-1648. PubMed ID: 27578022
[TBL] [Abstract][Full Text] [Related]
42. Age-related differences in kidney injury biomarkers induced by cisplatin.
Shin YJ; Kim TH; Won AJ; Jung JY; Kwack SJ; Kacew S; Chung KH; Lee BM; Kim HS
Environ Toxicol Pharmacol; 2014 May; 37(3):1028-39. PubMed ID: 24751685
[TBL] [Abstract][Full Text] [Related]
43. Pharmacokinetics of cisplatin and relation to nephrotoxicity in paediatric patients.
Erdlenbruch B; Nier M; Kern W; Hiddemann W; Pekrun A; Lakomek M
Eur J Clin Pharmacol; 2001 Aug; 57(5):393-402. PubMed ID: 11599657
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of novel renal biomarkers with a cisplatin model of kidney injury: gender and dosage differences.
Pinches M; Betts C; Bickerton S; Burdett L; Thomas H; Derbyshire N; Jones HB; Moores M
Toxicol Pathol; 2012 Apr; 40(3):522-33. PubMed ID: 22491933
[TBL] [Abstract][Full Text] [Related]
45. Monitoring treatment of acute kidney injury with damage biomarkers.
Pianta TJ; Succar L; Davidson T; Buckley NA; Endre ZH
Toxicol Lett; 2017 Feb; 268():63-70. PubMed ID: 28065798
[TBL] [Abstract][Full Text] [Related]
46. Correlation of prechemotherapy urinary megalin ectodomain (A-megalin) levels with the development of cisplatin-induced nephrotoxicity: a prospective observational study.
Shoji S; Hosojima M; Kabasawa H; Kondo R; Miura S; Watanabe S; Aoki N; Kaseda R; Kuwahara S; Tanabe N; Hirayama Y; Narita I; Kikuchi T; Kagamu H; Saito A
BMC Cancer; 2019 Dec; 19(1):1170. PubMed ID: 31791266
[TBL] [Abstract][Full Text] [Related]
47. Comparison of the MesoScale Discovery and Luminex multiplex platforms for measurement of urinary biomarkers in a cisplatin rat kidney injury model.
Pavkovic M; Riefke B; Gutberlet K; Raschke M; Ellinger-Ziegelbauer H
J Pharmacol Toxicol Methods; 2014; 69(2):196-204. PubMed ID: 24333954
[TBL] [Abstract][Full Text] [Related]
48. A Canadian Study of Cisplatin Metabolomics and Nephrotoxicity (ACCENT): A Clinical Research Protocol.
Jain A; Huang R; Lee J; Jawa N; Lim YJ; Guron M; Abish S; Boutros PC; Brudno M; Carleton B; Cuvelier GDE; Gunaratnam L; Ho C; Adeli K; Kuruvilla S; Lajoie G; Liu G; Nathan PC; Rod Rassekh S; Rieder M; Waikar SS; Welch SA; Weir MA; Winquist E; Wishart DS; Zorzi AP; Blydt-Hansen T; Zappitelli M; Urquhart B
Can J Kidney Health Dis; 2021; 8():20543581211057708. PubMed ID: 34820133
[TBL] [Abstract][Full Text] [Related]
49. Using intracellular metabolic profiling to identify novel biomarkers of cisplatin-induced acute kidney injury in NRK-52E cells.
Kim HR; Park JH; Lee SH; Kwack SJ; Lee J; Kim S; Yoon S; Kim KB; Lee BM; Kacew S; Kim HS
J Toxicol Environ Health A; 2022 Jan; 85(1):29-42. PubMed ID: 34445936
[TBL] [Abstract][Full Text] [Related]
50. Does the number of cycles of cisplatin based chemotherapy have any effect on renal function in patients with testicular germ cell tumor?
Suer E; Mermerkaya M; Gülpınar Ö; Afandiyev F; Baltacı S; Türkölmez K; Bedük Y
J Urol; 2013 Dec; 190(6):2081-5. PubMed ID: 23764076
[TBL] [Abstract][Full Text] [Related]
51. Assessing the recovery from prerenal and renal acute kidney injury after treatment with single herbal medicine via activity of the biomarkers HMGB1, NGAL and KIM-1 in kidney proximal tubular cells treated by cisplatin with different doses and exposure times.
Oh SM; Park G; Lee SH; Seo CS; Shin HK; Oh DS
BMC Complement Altern Med; 2017 Dec; 17(1):544. PubMed ID: 29258482
[TBL] [Abstract][Full Text] [Related]
52. A multiplexed UPLC-MS/MS assay for the simultaneous measurement of urinary safety biomarkers of drug-induced kidney injury and phospholipidosis.
Tengstrand E; Zhang H; Liu N; Dunn K; Hsieh F
Toxicol Appl Pharmacol; 2019 Mar; 366():54-63. PubMed ID: 30653977
[TBL] [Abstract][Full Text] [Related]
53. In vitro evaluation of biomarkers for cisplatin-induced nephrotoxicity using HK-2 human kidney epithelial cells.
Sohn SJ; Kim SY; Kim HS; Chun YJ; Han SY; Kim SH; Moon A
Toxicol Lett; 2013 Mar; 217(3):235-42. PubMed ID: 23287709
[TBL] [Abstract][Full Text] [Related]
54. Identification of urinary candidate biomarkers of cisplatin-induced nephrotoxicity in patients with carcinoma.
Jiang W; Ma T; Zhang C; Tang X; Xu Q; Meng X; Ma T
J Proteomics; 2020 Jan; 210():103533. PubMed ID: 31629959
[TBL] [Abstract][Full Text] [Related]
55. The Predictive Role of the Biomarker Kidney Molecule-1 (KIM-1) in Acute Kidney Injury (AKI) Cisplatin-Induced Nephrotoxicity.
Tanase DM; Gosav EM; Radu S; Costea CF; Ciocoiu M; Carauleanu A; Lacatusu CM; Maranduca MA; Floria M; Rezus C
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31652595
[TBL] [Abstract][Full Text] [Related]
56. Netrin-1 and kidney injury. II. Netrin-1 is an early biomarker of acute kidney injury.
Reeves WB; Kwon O; Ramesh G
Am J Physiol Renal Physiol; 2008 Apr; 294(4):F731-8. PubMed ID: 18234954
[TBL] [Abstract][Full Text] [Related]
57. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.
Peters HP; Waanders F; Meijer E; van den Brand J; Steenbergen EJ; van Goor H; Wetzels JF
Nephrol Dial Transplant; 2011 Nov; 26(11):3581-8. PubMed ID: 21467131
[TBL] [Abstract][Full Text] [Related]
58. Does the kidney injury molecule-1 predict cisplatin-induced kidney injury in early stage?
Tekce BK; Uyeturk U; Tekce H; Uyeturk U; Aktas G; Akkaya A
Ann Clin Biochem; 2015 Jan; 52(Pt 1):88-94. PubMed ID: 24670880
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of renal function using the level of neutrophil gelatinase-associated lipocalin is not predictive of nephrotoxicity associated with cisplatin-based chemotherapy.
Kos FT; Sendur MA; Aksoy S; Celik HT; Sezer S; Civelek B; Yaman S; Zengin N
Asian Pac J Cancer Prev; 2013; 14(2):1111-4. PubMed ID: 23621196
[TBL] [Abstract][Full Text] [Related]
60. Identification of a sensitive urinary biomarker, selenium-binding protein 1, for early detection of acute kidney injury.
Kim KS; Yang HY; Song H; Kang YR; Kwon J; An J; Son JY; Kwack SJ; Kim YM; Bae ON; Ahn MY; Lee J; Yoon S; Lee BM; Kim HS
J Toxicol Environ Health A; 2017; 80(9):453-464. PubMed ID: 28665768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
